Background: Topiramate (TPM) decreases tumor necrosis factor-alpha (TNF-α) and oxidative stress. We investigated protective effects of TPM on cell damage in kidney tissue during ischemia-reperfusion (I/R) damage. Methods: A total of 30 male Wistar albino rats were divided into three groups: control, I/R, and I/R plus TPM (I/ R+TPM). Laparotomy without I/R injury was performed in control group. After laparotomy, cross ligation of infrarenal abdominal aorta was applied for two hours in I/R groups which was followed by two hours of reperfusion. TPM (100 mg/kg/day) was orally administrated to animals in the I/R+TPM group for seven consecutive days before I/R. Results: The I/R group's TNF-α and interleukin-1 beta (IL-1β) levels were signifi cantly higher (1184.2 ± 129.1 pg/mg protein; 413.1 ± 28.8 pg/mg protein, respectively) than those of the control (907.8 ± 113.0 pg/mg protein, p = 0.002; 374.7 ± 23.7 pg/mg protein, p = 0.010, respectively) and I/R+TPM groups (999.5 ± 115.2 pg/ mg protein, p < 0.001; 377.9 ± 30.9 pg/mg protein, p = 0.007, respectively). Conclusion: TPM may partially prevent renal damage in rats. The opening of new horizons of this kind of knowledge will help understand the complex challenge in the prevention of renal I/R damage (Tab. 1, Fig. 3, Ref. 42). Text in PDF www.elis.sk.
Introduction
Renal ischemia/reperfusion (I/R) injury affects the prognosis of patients in a wide range of clinical situations including transplantation, renal resection surgery, abdominal trauma, and hemorrhagic shock and aorta injury during abdominal surgery (1) . Aortic occlusion and reperfusion produce distant organ injury by multiple mechanisms including neutrophilic infi ltration and the generation of reactive oxygen species (ROS) and cytokines (2, 3) . As shown in the present fi ndings, high activities of markers such as tumor necrosis factor-alpha (TNF-α) and Interleukin-1 beta (IL-1β) increase ischemic kidney tissue damage that occurs during I/R injury (4, 5) . The release of the mediators TNF-α and IL-1β starts at the beginning of reperfusion and increases during the early phase of I/R in kidney (6, 7) . The surge of oxygen to low oxygenated tissues causes increased production of ROS by TNF-α and IL-1β (8) . The apoptosis pathway is activated as a result of mitochondrial damage caused by ROS. Apoptosis plays also a major role in kidney injury induced by I/R. Topiramate (TPM), which is a sulfamate-substituted monosaccharide, is used in neurotherapy for the management of epilepsy and migraine (9) . It is documented to possess weight-reducing properties in addition to insulin resistance-improving effects (10, 11) . It has been demonstrated that TPM decreases TNF-α and oxidative stress in addition to being an effective antioxidant (11, 12, 13) . The inhibition of TNF-α release or its neutralization with anti-TNF-α antibodies decreases the number of neutrophils infi ltrating the kidney and reduces I/R injury (14) . Carbonic anhydrase (CA)-II is a zinc metallo-enzyme that catalyzes the reversible hydration of CO 2 to form carbonic acid (H 2 CO 3 ). CA-II has a wide tissue distribution, being found especially kidney (proximal tubules and collecting duct) (15) . Previous study reported that TPM behaves as a very potent inhibitor of human CA-II (16) . Another study showed that oxidative stress induced by diabetes has increased CA activity in the diabetic group more than in the control group (17) .
The aim of this study was to investigate whether the inhibition of TNF-α and IL-1β by TPM ameliorates I/R-induced kidney tissue injury by suppressing cell apoptosis.
Materials and methods

Animals
Thirty Wistar albino male rats, weighing 250-300 g (12-15 weeks old), were used in the present study. The rats were randomly divided into three experimental groups: the control group (n = 10), the I/R group (n = 10), and the I/R plus TPM (I/R+TPM) group (n = 10). This research was performed in accordance with the Guide for the Care and Use of Laboratory Animals, (NIH, 1985) and approved by the local ethical committee at the Recep Tayyip Erdogan University Medical School (Approval numbers: 2012/10).
Experimental design
Rats in the control groups received saline solution. Midline laparotomy and dissection of the infrarenal abdominal aorta (IAA) without occlusion was performed in the control group. However, laparotomy and clamping of the IAA for 120 min, followed by 120 min of reperfusion was carried out in the I/R group. I/R+TPM groups, TPM (100 mg/kg/day, Topamax ®, Johnson&Johnson) was orally (via gastric gavage) administered for seven consecutive days before I/R (18) . At the end of seven days, 120 min of ischemia and 120 min of reperfusion was performed in the I/R+TPM group.
Aortic I/R
The I/R model was designed similarly to previous studies (2, 19) . Male Wistar rats, were anesthetized intraperitoneally with ketamine hydrochloride (Ketalar, 50 mg/kg intramuscularly; Eczacibasi, Istanbul, Turkey), and placed supine on a heated mat. 10 ml per hour of sterile saline was injected subcutaneously into the neck of the animals to replace surgical fl uid losses from evaporation. A midline laparotomy was performed and a window dissected in the retroperitoneum to expose the infrarenal aorta. A microvascular clamp was placed across the IAA. The abdomen was closed, and the wound was covered with plastic wrap to minimize the loss of heat and fl uid. After 120 min, the microvascular clamp on the IAA was removed and the lower limb reperfusion was maintained for 120 min. Aortic occlusion and reperfusion was confi rmed by the loss and reappearance of the pulsation on the distal aorta. At the end of the reperfusion, a median sternotomy was performed and the blood samples were drawn from the right ventricles of all rats for biochemical analyses. All rats were killed, and their kidneys were removed meticulously.
Biochemical parameters
The blood samples (10 mL) were collected into tubes. The blood was separated by centrifugation at 3000 rpm for 10 min after standing at room temperature for 15 min. Biochemical parameters including urea and creatinine were determined from serum using the determined commercial kits (Architect c 16000, Abbott Laboratories, USA).
Tissue homogenates
The samples were homogenized in PBS, pH 7.4, and centrifuged at 10,000 g for 20 min. Aliquot of the supernatant was put into tubes and frozen at -80 °C. The parameters were checked within one month.
Measurement of protein
Tissue homogenate protein assay is a turbidimetric procedure in which benzethonium chloride is used as the protein denaturing agent. Proteins in the form of a fi ne suspension were quantitated turbidimetrically at 404 ηm. (Architect c 16000, Abbott Laboratories, USA).
TNF-α
The TNF-α concentration was measured using the enzymelinked immunosorbent assay (ELISA) method. We used the commercially available rat TNF-α ELISA kit (eBioscience, Vienna, Austria). When dividing the obtained values by protein levels, the fi nal results were obtained as pg/mg protein.
IL-1β
The IL-1β concentration was also measured using the enzymelinked immunosorbent assay (ELISA) method. We used the commercially available rat IL-1β ELISA kit (eBioscience, Vienna, Austria). When dividing the obtained values by protein levels, the fi nal results were obtained as pg/mg protein.
Immunohistological evaluation
For immunohistochemical staining, 3-4 μm-thick sections were cut and allowed to stand in xylene for 20 minutes before the application of the alcohol series (50-100%) and then stand for 10 min in H2O2 solution. After being washed by PBS they were heated in a citrate buffer solution by 800 Watt power for 4-5 min and then allowed to stand in a secondary blocker substance for 20 min. Each slide standed for 75 min in different dilutions of primary antibody [TNF-α 1 μg/ml and for Carbonic anhydrase (CA) II 1/250-/500] before being stained by Anti-CA II (cod: ab124687, Abcamplc, Cambridge CB4 0FL UK), and Anti-TNF-α antibody (cod: ab66579, Abcamplc, Cambridge CB4 0FL UK). Diaminobenzidine solution was used as an achromogen and Mayer's hematoxylin was used as a counterstain for 3-5 min. PBS was used as a negative controller. Preparations were photographed after being covered with appropriate covering materials. As a result of immunohistochemical staining, preparations were divided into four categories according to the tissues' percentage of immunopositive reaction areas as mild (+), moderate (++), severe (+++), and very severe (++++). The blocked tissues were cut into 4-5 μm-thick sections before being stained by hematoxylin and eosin (H&E) for histopathological examination, and then areas found appropriate for histopathological evaluation were photographed. Tissues were blindly evaluated by two histologists.
Statistical analyses
The results are presented as mean ± SD. The Kruskal-Wallis test was used to compare the groups. A Bonferroni adjusted MannWhitney U test was used to compare the two groups. Statistically signifi cant differences were obtained at a p value of less than 0.05.
Results
Biochemical parameters
The I/R group's creatinine levels were signifi cantly higher (0.55 ± 0.02 mg/dl) than those of the control (0.42 ± 0.05 mg/dl, p < 0.001) and I/R+TPM groups (0.49 ± 0.03 mg/dl, p < 0.001). The I/R group's urea levels were signifi cantly higher (60.0 ± 17.4 mg/dl) than those of the control (39.8 ± 4.6 mg/dl, p = 0.004). The I/R group's TNF-α levels (1184.2 ± 129.1 pg/mg protein) were signifi cantly higher than those of the control (907.8 ± 113.0 pg/ mg protein, p = 0.002) and I/R+TPM groups (999.5 ± 115.2 pg/ mg protein, p < 0.001). The I/R group's IL-1β levels (413.1 ± 28.8 pg/mg protein) were signifi cantly higher than those of the control (374.7 ± 23.7pg/mg protein, p = 0.007) and I/R+TPM groups (377.9 ± 30.9, p = 0.010 pg/mg protein).
Histologic parameters
Parameters of (H&E) No textural or cellular deformity was found in the histopathological examination of the control group's kidneys (Fig. 1A) .
In I/R animal group's kidneys which was related to edema in both proximal and distal tubules secondary to dilatation, edema, and fl uid accumulation in the lumen. In the acute phase of reperfusion, vasoconstriction and an increase in the number of leukocytes were observed in the medulla and cortex border. The lumens of distal tubules were quite enlarged with tubular deformities related to epithelial loss (Fig. 1B) .
In I/R+TPM animal group was showed less tissue and cellular deformity than in the I/R group. Even though the dilatations of distal tubules were decreased, they were similar to the control group. In the cells of the proximal tubules, while sporadic degeneration was observed, basophilic stains of the nuclei were noted. Even if the edema and epithelial loss of the tubules cells had decreased, they did not completely disappear. Despite a decrease in edema formation due to tubular structure deformation and cellular loss, there was still edema in the lumen (Fig. 1C) .
Immunohistochemical parameters
The CA results are shown in Figure 2 , and TNF-α results are shown in Figure 3 . All histologic results are shown in Table 1 .
Discussion
To our knowledge, the present study is the fi rst one which investigates the effects of TPM on I/R-induced renal injury in a rat model. Pretreatment with TPM prevents renal dysfunction, attenuates renal tubular damage, and reduces the infl ammatory response at the early stage of renal I/R, suggesting that TPM was able to protect against renal injury induced by I/R in rats. Acute kidney injury due to I/R is characterized by vasoconstriction, oxidative stress, apoptosis, and infl ammation (20) . Renal tissue damage starts immediately after the onset of ischemia due to a dramatic decrease in oxygen and nutrition. To restore renal blood perfusion as soon as possible, it is critical to decrease renal injury. However, many animal and clinical studies have shown that subsequent reperfusion worsens cell metabolic disorders, leading to additional damages in renal structure and function (21, 22, 23) . Many mechanisms are included in renal I/R injury such as the infi ltration of infl ammatory cells; the generation of infl ammatory factors like cytokines, chemokines and, other pro-infl ammatory mediators; and the accumulation of ROS (24,2 5). It has been reported that I/R leads to tubular dilatation, congestion, brush border loss, and epithelial cell necrosis that aggravates renal structural damages by ROS (26) . Tubular cell injury as well as diffuse endothelial cell damage has been demonstrated in I/R and both tubular and endothelial cells contribute to the infl ammatory process. Infl ammation has become recognized as a critical component of I/R injury (27, 28) .
It has been shown that increased TNF-α and IL-1β levels are markers for apoptosis (29) . Elevations of these cytokine levels activate NF-κB, which stimulates nuclear receptors, leading to greater release of these cytokines and more cellular damage. Protracted or excessive endoplasmic reticulum (ER) stress and pro-infl ammatory cytokines trigger renal cell death through the "mitochondrial" or intrinsic pathway of apoptosis (30) . A previous study conducted on the protective effect of TPM after cerebral I/R injury has shown marked suppression of neuronal cell death in the hippocampal CA1 area of ischemic gerbils after treatment with TPM (31). In our study, the I/R group's TNF-α and IL-1β levels were signifi cantly higher than those of the control group. The levels of TNF-α and IL-1β of the TPM-treated group were signifi cantly lower than the I/R group and similar to the control group. TNF-α activity was immunohistochemically shown to be low in the I/R+TPM group. TPM as an inhibitor of TNF-α and an antioxidant during I/R injury suppresses the release of cytokines and decreases/improves renal damage.
CA is a widespread metaloenzyme that catalyzes the biochemical reaction of CO 2 hydration to the bicarbonate ion and proton (32) . This reaction makes CA engage in various physiological processes such as pH and CO 2 homeostasis, electrolyte secretion, gluconeogenesis, lipogenesis, ureagenesis and bone resorption, calcifi cation, and tumorigenicity (33) . CA II, which is synthesized by renal tubules, has a role in Na + and H 2 O reabsorption (17) . In a previous study, CA III overexpressing cells were used as a model to test the role of CA III in a cellular defense system against oxidative stress (34) . However, CA II did not seem to have this capacity; the increased level of CAII may be harmful (17) . It is present in most tissues with high CA II enzyme activity, including gastric cancer, liver and bile duct cancer, colon cancer, renal cell carcinoma, melanoma, brain astrocytic tumors, pancreatitis cells in mice, and cardiomyocyte hypertrophy (35) . Cancer cells have a higher replication rate than normal cells and thus require a high fl ux of bicarbonate into these metabolic pathways. Providing that bicarbonate is a substrate for carbonic anhydrase, isoforms play an important role in tumor cell growth (36) . Inhibition of CA II by acetazolamide has been shown in vitro to strongly reduce the invasiveness of some renal cancer cell lines (37) . On the other hand, H 2 O 2 is a major factor that induces apoptosis. In previous experiments, H 2 O 2 induced cellular apoptosis (38) . Most studies describing the role of CO 2 /HCO 3 − in biological oxidations have been conducted in vitro and less commonly in vivo systems to which oxidants were added exogenously promoting overt oxidative stress followed by an evaluation of the effects of HCO 3 − . CO 2 / HCO 3 − levels affect tissues under physiologically suitable conditions, providing indirect evidence of carbonate radicals' participation in biologically relevant processes (39, 40) . Previous study found that although various concentrations of CO 2 /HCO 3 − have no effect under basal conditions, when I/R was applied in the presence of higher CO 2 /HCO 3 − , it resulted in greater functional loss associated with higher oxidative damage in all models (41) . TPM inhibits CA enzymes. Many studies have shown that TPM lowers serum HCO 3 -levels (42). In our study, the high level of CA II in the I/R group indirectly indicates the expression of high levels of bicarbonate during I/R. Excessive bicarbonate may lead to activation of the apoptosis pathway related to increased levels of free radicals and oxidative stress. The TPM-treated group's CA II activity was higher than the control group. However, it was lower than that of the I/R group. TPM partially inhibited CA II. TPM has not been reported in the literature on the experimental abdominal aorta I/R model yet, as higher dosages may be needed to inhibit CA II.
In conclusion, TPM signifi cantly improved renal function recovery after I/R injury and effectively inhibited the induction of pro-infl ammatory mediators by suppressing the NF-κB signaling pathway. Our results substantiate TPM as a novel therapeutic agent for the treatment of acute ischemic renal failure. 
